GCT names Tatiana Fedorova, MD, PhD a Head of Clinical Department
Dr. Fedorova has joined GCT team this July as a Head of the Clinical Department in Russia. She has a unique combination of training and higher education in medical field, research and pedagogy. She is an MD, PhD, MPH, ASSC PROF and has more than 20 years of direct clinical trial experience at the country and on a global level.
Tatiana’s broad experience within the clinical trial industry started to accumulate as she entered at the CRA level while still at the university, and shortly after graduation she continued to a Project Manager position at one of the Russian CROs. During her carrier in clinical research, she has been involved in many studies as a Principal Investigator, Medical Monitor, Medical Writer and Medical Advisor. She is used to work in the diverse workplace environment in a number of countries, including Russia, Sri-Lanka, Malaysia, and Norway.
Tatiana has previously directed the establishment of a local Russian office for the Nordic CRO from scratch and acted as their Country Manager for many years. She has experience arranging for every component of a clinical trial, from A to Z. Up until now Tatiana acted as a Sponsor representative in the Russian Federation and Ukraine, providing close oversight of local clinical operations activities for the global biotech company.
As a Head of the Clinical Department at GCT Tatiana oversees all aspects of defining the clinical operations strategy, as well as successful planning, executing, analyzing, and reporting on of company’s ongoing clinical trials in Russia ensuring that goals are met and results are delivered on time, within budget and in compliance with Good Clinical Practices, laws and regulations. Tatiana will be continuously involved into corporate training sessions, supervision of CRA and PM activities, identifying and catching any possible problems before they can have the avoidable effect on any the study.
Updated: October 16, 2017